Yesterday, July 8, 2013, 142 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1.15 to $10,873,958.42. Highlighted Stocks Traded by Insiders: Ironwood Pharmaceuticals (IRWD) - FREE Research Report Hecht Peter M who is Chief Executive Officer at IRONWOOD PHARMA bought 184,758 shares at $0.20 per share for a total value of $60,000.00 on July 8, 2013. Following this transaction, the Chief Executive Officer owned 7.5 million shares meaning that the stake was boosted by 2.51% with the 184,758 share acquisition. The shares most recently traded at $10.52, down $0.03, or 0.28% since the insider transaction. The average volume for Ironwood Pharmaceuticals has been 1.3 million shares per day over the past 30 days. Ironwood Pharmaceuticals has a market cap of $981.3 million and is part of the health care sector and health services industry. Shares are down 5.42% year to date as of the close of trading on Monday. Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. Currently there are 3 analysts that rate Ironwood Pharmaceuticals a buy, 2 analysts rate it a sell, and 6 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on IRWD - FREETheStreet Quant Ratings rates Ironwood Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally high debt management risk. Get the full Ironwood Pharmaceuticals Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.